These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 17105603

  • 1. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma.
    Gironés N, Bueno JL, Carrión J, Fresno M, Castro E.
    Vox Sang; 2006 Nov; 91(4):285-91. PubMed ID: 17105603
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets.
    Castro E, Gironés N, Bueno JL, Carrión J, Lin L, Fresno M.
    Transfusion; 2007 Mar; 47(3):434-41. PubMed ID: 17319823
    [Abstract] [Full Text] [Related]

  • 3. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM, Martins TA, Caldas IS, Diniz LF, Machado-Coelho GL, Carneiro CM, Oliveira Rde P, Talvani A, Lana M, Bahia MT.
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [Abstract] [Full Text] [Related]

  • 4. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R.
    Transfus Apher Sci; 2007 Oct; 37(2):131-7. PubMed ID: 17950672
    [Abstract] [Full Text] [Related]

  • 5. Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure.
    Romanha AJ, Alves RO, Murta SM, Silva JS, Ropert C, Gazzinelli RT.
    J Infect Dis; 2002 Sep 15; 186(6):823-8. PubMed ID: 12198617
    [Abstract] [Full Text] [Related]

  • 6. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.
    Pinge-Filho P, Peron JP, de Moura TR, Menolli RA, Graça VK, Estevão D, Tadokoro CE, Jankevicius JV, Rizzo LV.
    Immunol Lett; 2005 Jan 31; 96(2):283-90. PubMed ID: 15585334
    [Abstract] [Full Text] [Related]

  • 7. Interferon-gamma induced nitric oxide mediates in vitro neuronal damage by Trypanosoma cruzi-infected macrophages.
    Almeida-Leite CM, Galvão LM, Afonso LC, Cunha FQ, Arantes RM.
    Neurobiol Dis; 2007 Jan 31; 25(1):170-8. PubMed ID: 17056264
    [Abstract] [Full Text] [Related]

  • 8. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
    Lo Presti MS, Rivarola HW, Bustamante JM, Fernández AR, Enders JE, Fretes R, Gea S, Paglini-Oliva PA.
    Int J Antimicrob Agents; 2004 Jun 31; 23(6):634-6. PubMed ID: 15194137
    [Abstract] [Full Text] [Related]

  • 9. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.
    Arantes JM, Francisco AF, de Abreu Vieira PM, Silva M, Araújo MS, de Carvalho AT, Pedrosa ML, Carneiro CM, Tafuri WL, Martins-Filho OA, Elói-Santos SM.
    Exp Parasitol; 2011 Aug 31; 128(4):401-8. PubMed ID: 21620835
    [Abstract] [Full Text] [Related]

  • 10. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S, Santos FM, de Lana M, Diniz LF, Machado-Coelho GL, Veloso VM, Bahia MT.
    Exp Parasitol; 2008 Mar 31; 118(3):315-23. PubMed ID: 17945216
    [Abstract] [Full Text] [Related]

  • 11. Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood.
    Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA.
    Transfusion; 2012 Feb 31; 52(2):409-16. PubMed ID: 21827502
    [Abstract] [Full Text] [Related]

  • 12. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM, Caldas S, de Assis Cáu SB, Crepalde GP, de Lana M, Machado-Coelho GL, Veloso VM, Bahia MT.
    Exp Parasitol; 2008 Dec 31; 120(4):385-90. PubMed ID: 18823980
    [Abstract] [Full Text] [Related]

  • 13. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease.
    Borges CL, Cecchini R, Tatakihara VL, Malvezi AD, Yamada-Ogatta SF, Rizzo LV, Pinge-Filho P.
    Immunol Lett; 2009 Mar 24; 123(1):38-45. PubMed ID: 19428550
    [Abstract] [Full Text] [Related]

  • 14. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
    Solana ME, Alba Soto CD, Fernández MC, Poncini CV, Postan M, González Cappa SM.
    Parasitology; 2009 May 24; 136(6):627-39. PubMed ID: 19366478
    [Abstract] [Full Text] [Related]

  • 15. Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice.
    Rivarola HW, Fernández AR, Enders JE, Fretes R, Gea S, Suligoy M, Palma JA, Paglini-Oliva P.
    Ann Trop Med Parasitol; 1999 Oct 24; 93(7):695-702. PubMed ID: 10715697
    [Abstract] [Full Text] [Related]

  • 16. Trypanocidal effects of promethazine.
    Fernández AR, Fretes R, Rubiales S, Lacuara JL, Paglini-Oliva P.
    Medicina (B Aires); 1997 Oct 24; 57(1):59-63. PubMed ID: 9435371
    [Abstract] [Full Text] [Related]

  • 17. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi.
    Cutrullis RA, Postan M, Petray PB, Corral RS.
    Pathobiology; 2009 Oct 24; 76(4):170-80. PubMed ID: 19571606
    [Abstract] [Full Text] [Related]

  • 18. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X, Yonemitsu Y, Chou B, Yoshida K, Tanaka S, Hasegawa M, Tetsutani K, Ishida H, Himeno K, Hisaeda H.
    Vaccine; 2009 Oct 19; 27(44):6154-9. PubMed ID: 19712768
    [Abstract] [Full Text] [Related]

  • 19. Trypanosoma cruzi: Serum levels of nitric oxide and expression of inducible nitric oxide synthase in myocardium and spleen of dogs in the acute stage of infection with metacyclic or blood trypomastigotes.
    Vieira PM, Francisco AF, de Souza SM, Malaquias LC, Reis AB, Giunchetti RC, Veloso VM, de Lana M, Tafuri WL, Carneiro CM.
    Exp Parasitol; 2009 Jan 19; 121(1):76-82. PubMed ID: 18983995
    [Abstract] [Full Text] [Related]

  • 20. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.
    Marinho CR, Nuñez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, Bucci DZ, Sardinha LR, Lima MR, Alvarez JM.
    Scand J Immunol; 2007 Jan 19; 66(2-3):297-308. PubMed ID: 17635807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.